| pubmed-article:3087902 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3087902 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:3087902 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:3087902 | lifeskim:mentions | umls-concept:C0678108 | lld:lifeskim |
| pubmed-article:3087902 | lifeskim:mentions | umls-concept:C0037864 | lld:lifeskim |
| pubmed-article:3087902 | lifeskim:mentions | umls-concept:C0085696 | lld:lifeskim |
| pubmed-article:3087902 | lifeskim:mentions | umls-concept:C0683278 | lld:lifeskim |
| pubmed-article:3087902 | lifeskim:mentions | umls-concept:C0301872 | lld:lifeskim |
| pubmed-article:3087902 | lifeskim:mentions | umls-concept:C0376249 | lld:lifeskim |
| pubmed-article:3087902 | lifeskim:mentions | umls-concept:C0337037 | lld:lifeskim |
| pubmed-article:3087902 | lifeskim:mentions | umls-concept:C0458083 | lld:lifeskim |
| pubmed-article:3087902 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:3087902 | pubmed:dateCreated | 1986-7-25 | lld:pubmed |
| pubmed-article:3087902 | pubmed:abstractText | A new method of treatment of patients with chronic prostatitis and sterility by means of ultra-high frequency (60 W) electric field applied bitemporally has been proposed. During treatment 82% of the patients showed an increase in the number of spermatozoa in 1 ml of ejaculate; the percentage of movable and morphologically normal spermatozoa has increased. Patients with chronic prostatitis and sterility showed in the prostatic secrete before treatment a predominance of B-lymphocytes over T-lymphocytes. After treatment the number of T-lymphocytes in the prostatic secrete increased and the content of B-lymphocytes decreased. In the subpopulation of T-lymphocytes the content of T-suppressors increased, the content of T-helpers and O-lymphocytes decreased. At the same time patients with sterility showed an increase in blood testosterone level and an FSH decrease. Out of 67 wives of the patients with sterility 50 reported pregnancy within 6 months after beginning of the treatment. | lld:pubmed |
| pubmed-article:3087902 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3087902 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3087902 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3087902 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3087902 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3087902 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3087902 | pubmed:issn | 0301-1623 | lld:pubmed |
| pubmed-article:3087902 | pubmed:author | pubmed-author:KozhinovaE... | lld:pubmed |
| pubmed-article:3087902 | pubmed:author | pubmed-author:BobkovaA SAS | lld:pubmed |
| pubmed-article:3087902 | pubmed:author | pubmed-author:KarpukhinI... | lld:pubmed |
| pubmed-article:3087902 | pubmed:author | pubmed-author:BogolyubovV... | lld:pubmed |
| pubmed-article:3087902 | pubmed:author | pubmed-author:RazuvayevA... | lld:pubmed |
| pubmed-article:3087902 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3087902 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:3087902 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3087902 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3087902 | pubmed:pagination | 89-97 | lld:pubmed |
| pubmed-article:3087902 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:3087902 | pubmed:meshHeading | pubmed-meshheading:3087902-... | lld:pubmed |
| pubmed-article:3087902 | pubmed:meshHeading | pubmed-meshheading:3087902-... | lld:pubmed |
| pubmed-article:3087902 | pubmed:meshHeading | pubmed-meshheading:3087902-... | lld:pubmed |
| pubmed-article:3087902 | pubmed:meshHeading | pubmed-meshheading:3087902-... | lld:pubmed |
| pubmed-article:3087902 | pubmed:meshHeading | pubmed-meshheading:3087902-... | lld:pubmed |
| pubmed-article:3087902 | pubmed:meshHeading | pubmed-meshheading:3087902-... | lld:pubmed |
| pubmed-article:3087902 | pubmed:meshHeading | pubmed-meshheading:3087902-... | lld:pubmed |
| pubmed-article:3087902 | pubmed:meshHeading | pubmed-meshheading:3087902-... | lld:pubmed |
| pubmed-article:3087902 | pubmed:meshHeading | pubmed-meshheading:3087902-... | lld:pubmed |
| pubmed-article:3087902 | pubmed:meshHeading | pubmed-meshheading:3087902-... | lld:pubmed |
| pubmed-article:3087902 | pubmed:meshHeading | pubmed-meshheading:3087902-... | lld:pubmed |
| pubmed-article:3087902 | pubmed:meshHeading | pubmed-meshheading:3087902-... | lld:pubmed |
| pubmed-article:3087902 | pubmed:meshHeading | pubmed-meshheading:3087902-... | lld:pubmed |
| pubmed-article:3087902 | pubmed:meshHeading | pubmed-meshheading:3087902-... | lld:pubmed |
| pubmed-article:3087902 | pubmed:year | 1986 | lld:pubmed |
| pubmed-article:3087902 | pubmed:articleTitle | Dynamics of spermatogenesis, hormonal and immune response of patients suffering from chronic prostatitis and sterility under bitemporal treatment with an ultra-high frequency electric field. | lld:pubmed |
| pubmed-article:3087902 | pubmed:publicationType | Journal Article | lld:pubmed |
